New Insights into the Mechanism for VACM-1/cul5 Expression in Vascular Tissue invivo

International Review of Cell and Molecular Biology

Volumn 313, Issue , 2014, Pages 79-101

  Burnatowska Hledin, Maria A ^a   Barney, Christopher C ^a  

^a HOPE COLLEGE   (United States)

Author keywords

Aquaporin; Cullin; Endothelium; Neddylation; Tissue expression; Ubiquitin proteasome system; VACM 1; Vasopressin activated calcium mobilizing receptor; Water deprivation

Indexed keywords

AQUAPORIN; CULLIN; CULLIN 5; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VASOPRESSIN ACTIVATED CALCIUM MOBILIZING 1; CUL5 PROTEIN, HUMAN; PROTEASOME; UBIQUITIN; WATER;

ARTICLE; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM; HEART FUNCTION; HUMAN; IN VIVO STUDY; KIDNEY COLLECTING TUBULE; MAMMAL CELL; NONHUMAN; OSMOTIC STRESS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE SPECIFICITY; VASCULAR TISSUE; WATER DEPRIVATION; ANIMAL; BLOOD VESSEL; ELECTROLYTE BALANCE; ENZYMOLOGY; METABOLISM;

ANIMALS; AQUAPORINS; BLOOD VESSELS; CULLIN PROTEINS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITIN; WATER; WATER-ELECTROLYTE BALANCE;

EID: 84908871703     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800177-6.00003-7     Document Type: Chapter

References (118)

1. Albelda S.N., Muller W.A., Buck C.A., Newman P.J. Molecular and cellular properties of PECAM-1 (endoCam/CD31): a novel vascular cell-cell adhesion molecule. J. Cell Biol. 1991, 114:1059-1068.
2. Allen S., Khan S., Al-Mohanna F., Batten Pl, Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J. Clin. Invest. 1998, 101:1064-1075.
3. An P., Duggal P., Wang L.H., O'Brien S.J., Donfield S., Goedert J.J., Phair J., Buchbinder S., Kirk G.D., Winkler C.A. Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals. PLoS Genet. 2007, 3:e19.
4. Arai T.J., Kasper S., Skaar J.R., Ali S.H., Takahashi C., DeCaprio J.A. Targeted disruption of p185/cul7 gene results in abnormal vascular morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9855-9860.
5. Arid W.C. Endothelial cell heterogeneity. Cold Spring Harb. Perspect. Med. 2012, 2:a006429.
6. d'Azzo A., Bongiovanni A., Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 2005, 6:429-441.
7. Baxter S.S., Carlson L.A., Mayer A.M., Hall M.L., Fay M.J. Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5. In Vitro Cell. Dev. Biol. Anim. 2009, 45:264-274.
8. Bergeron J.R., Huthoff H., Veselkov D.A., Beavil R.L., Simpson P.J., Matthews S.J., Malim M.H., Sanderson M.R. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-Containing ubiquitin ligase complex. PLoS Pathog. 2010, 6:e1000925.
9. Birkenkamp-Demtroeder K., Bongartz S., Gams E., Kupfer C., Schipke J.D., Schmitt M. Expression of water channels in the human heart. J. Clin. Basic Cardiol. 2003, 6:77-79.
10. Boulkroun S., Ruffieux-Daidié D., Vitagliano J.J., Poirot O., Charles R.P., Lagnaz D., Firsov D., Kellenberger S., Staub O. Vasopressin-inducible ubiquitin-specific protease 10 increases ENaC cell surface expression by deubiquitylating and stabilizing sorting nexin 3. Am. J. Physiol. 2008, 295:F889-F900.
11. Butterworth M.B., Edinger R.S., Frizzell R.A., Johnson J.P. Regulation of the epithelial sodium channel by membrane trafficking. Am. J. Physiol. 2009, 296:F10-F24.
12. Bradley S.E., Johnson A.E., Le I.P., Oosterhouse E., Hledin M.P., Marquez G.A., Burnatowska-Hledin M. Phosphorylation of VACM-1/cul5 by protein kinase A regulates its neddylation and antiproliferative effect. J. Biol. Chem. 2010, 285:4883-4895.
13. Brønd L., Müllertz K.M., Torp M., Nielsen J., Graebe M., Hadrup N., Nielsen S., Christensen S., Jonassen T.E. Congestive heart failure in rats is associated with increased collecting duct vasopressin sensitivity and vasopressin type 2 receptor reexternalization. Am. J. Physiol. 2013, 305:F1547-F1554.
14. Buchwalter A., Van Dort C., Schultz S., Smith R., Le I.P., Abbott J.L., Oosterhouse E., Johnson A.E., Hansen-Smith F., Burnatowska-Hledin M. Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype. Microvasc. Res. 2008, 75:155-168.
15. Bundzikova J., Pirnik Z., Zelena D., Mikkelsen J.D., Kiss A. Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats. Cell. Mol. Neurobiol. 2008, 28:1033-1047.
16. Burnatowska-Hledin M.A., Spielman W.S., Smith W.L., Shi P., Meyer J.M., Dewitt D.L. Expression cloning of an AVP-activated calcium-mobilizing receptor from rabbit kidney medulla. Am. J. Physiol. 1995, 268:F1198-F1210.
17. Burnatowska-Hledin M., Lazdins I.B., Listenberger L., Zhao P., Sharangpani A., Folta V., Card B. VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule. Am. J. Physiol. 1999, 276:F199-F209.
18. Burnatowska-Hledin M., Zhao P., Capps B., Poel A., Parmalee K., Mungall C., Sharangpani A.M., Listenberger L. VACM-1, a cullin gene family member, regulates cellular signaling. Am. J. Physiol. 2000, 279:C266-C273.
19. Burnatowska-Hledin M., Zeneberg A., Roulo A., Grobe J., Zhao P., Lelkes P.L., Clare P., Barney C. Expression ofVACM-1 protein in cultured rat adrenal endothelial cells is linked to the cell cycle. Endothelium 2001, 8:49-63.
20. Burnatowska-Hledin M.A., Kossoris J.B., Van Dort C.J., Shearer R.L., Murrey D.A., Abbott J.L., Kan C.E., Barney C.C. T47D breast cancer cell growth is inhibited by expression ofVACM-1, a cul-5 gene. Biochem. Biophys. Res. Commun. 2004, 319:817-825.
21. Byrd P.J., Stankovic T., McConville C.M., Smith A.D., Cooper P.R., Taylor A.M. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome Res. 1997, 7:71-75.
22. Carrier L. Too much of a good thing is bad: proteasome inhibition induces stressed hearts to fail. Cardiovasc. Res. 2010, 88:389-390.
23. Ceremuga T.E., Yao X.L., McCabe J.T. Vasopressin-activated calcium mobilizing (VACM-1) mRNA is present in peripheral organs and the central nervous system of the laboratory rat. Endocr. Res. 2001, 27:433-445.
24. Ceremuga T.E., Yao X.L., McCabe J.T. Cullin-5 is ubiquitous in the rat brain. Neurosci. Lett. 2003, 345:121-125.
25. Ceremuga T.E., Yao X.L., Xia Y., Mukherjee D., McCabe J.T. Osmotic stress increases cullin-5 (cul-5) mRNA in the rat cerebral cortex, hypothalamus, and kidney. Neurosci. Res. 2003, 45:305-311.
26. Ceremuga T.E., Yao X.L., Alam H.B., McCabe J.T. Alterations of cullin-5 mRNA levels in the rat central nervous system following hemorrhagic shock. Neurol. Res. 2003, 2:211-216.
27. Chhangani D., Joshi A.P., Mishra A. E3 ubiquitin ligases in protein quality control mechanism. Mol. Neurobiol. 2012, 45:571-585.
28. Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat. Rev. Drug Discov. 2002, 1:198-210.
29. Clapp C., Martinez de la Escalera G. Aquaporin-1: a novel promoter of tumor angiogenesis. Trends Endocrinol. Metab. 2006, 17:1-2.
30. Day S.M. The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am. J. Physiol. 2013, 304:H1283-H1293.
31. Deshaies R.J., Emberley E.D., Saha A. Control of cullin-ring ubiquitin ligase activity by nedd8. Subcell. Biochem. 2010, 54:41-56.
32. Devuyst O., Nielsen S., Cosyns J.P., Smith B.L., Agre P., Squifflet J.P., Pouthier D., Goffin E. Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am. J. Physiol. 1998, 275:H234-H242.
33. Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., Schulman B.A. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134:995-1006.
34. Echevarria M., Muñoz-Cabello A.M., Sánchez-Silva R., Toledo-Aral J.J., López-Barneo J. Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression. J. Biol. Chem. 2007, 282:30207-30215.
35. Egan J.R., Butler T.L., Au C.G., Tan Y.M., North K.N., Winlaw D.S. Myocardial water handling and the role of aquaporins. Biochim. Biophys. Acta 2006, 1758:1043-1052.
36. Ehrentraut S.F., Kominsky D.J., Glover L.E., Campbell E.L., Kelly C.J., Bowers B.E., Bayless A.J., Colgan S.P. Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response. J. Immunol. 2013, 190:392-400.
37. Ehrlich E.S., Wang T., Luao K., Xiao Z., Niewiadomska A.M., Martinez T., Xu W., Neckers L., Yu X.F. Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20330-20335.
38. Elfont R.M., Sokol H.W. Salt and water intake in Brattleboro rats with hypothalamic diabetes insipidus. Physiol. Behav. 1987, 39:53-61.
39. Endo M., Jain R.K., Witwer B., Brown D. Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas. Microvasc. Res. 1999, 58:89-98.
40. Fay M.J., Longo K.A., Karathanasis G.A., Shope D.M., Mandernach C.J., Leong J.R., Hicks A., Pherson K., Husian A. Analysis of cul-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol. Cancer 2003, 2:40.
41. Feng L., Allen N.S., Simo S., Cooper J.A. Cullin 5 regulates Dab1 protein levels and neuron positioning during cortical development. Genes Dev. 2007, 21:2717-2730.
42. Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y.C., Karin M. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004, 306:2271-2275.
43. Gurubhagavatula I., Amrani Y., Pratico D., Ruberg F.L., Albelda S.M., Panettieri R.A. Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J. Clin. Invest. 1998, 101:212-222.
44. Hendrix J., Doggen K., Weinberg E.O., Van Tongelen P., Fransen P., De Keulenaer G.W. Molecular diversity of cardiac endothelial cells invitro and invivo. Physiol. Genomics 2004, 19:198-206.
45. Herrmann J., Ciechanover A., Lerman L.O., Lerman A. The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc. Res. 2004, 61:11-21.
46. Herrmann J., Wohlert C., Saquner A.M., Flores A., Nesbitt L.L., Chade A., Lerman L.O., Lerman A. Primary proteasome inhibition results in cardiac dysfunction. Eur. J. Heart Fail. 2013, 15:614-623.
47. Heuzé M.L., Guibal F.C., Banks C.A., Conaway J.W., Conaway R.C., Cayre Y.E., Benecke A., Lutz P.G. ASB2 is an elongin BC-interacting protein that can assemble with cullin 5 and Rbx1 to reconstitute an E3 ligase complex. J. Biol. Chem. 2005, 280:5468-5474.
48. Hoque M.O., Soria J.C., Woo J.H., Lee T., Lee J., Jang S.J., Upadhyay S., Trink B., Monitto C., Desmaze C., Mao L., Sidransky D., Moon C. Aquaporin is overexpressed in lung cancer and stimulates NH-3 T3 cell proliferation and anchorage-independent growth. Am. J. Pathol. 2006, 168:1345-1353.
49. Hori T., Osaka F., Chiba T., Miyamoto C., Okabayashi K., Shimbara N., Kato S., Tanaka K. Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 1999, 18:6829-6834.
50. Hurbin A., Orcel H., Ferraz C., Moos F.C., Rabié A. Expression of the genes encoding the vasopressin-activated calcium-mobilizing receptor and the dual angiotensin II/vasopressin receptor in the rat central nervous system. J. Neuroendocrinol. 2000, 12:677-684.
51. Huang Y., Murakami T., Sano F., Knodo K., Nakaigawa N., Kishida T., Kubota T., Nagashima Y., Yao M. Expression of aquaporin 1 in primary renal tumors: a prognostic indictor of clear-cell renal cell carcinoma. Eur. Urol. 2009, 56:690-698.
52. Jackson D.E. The unfolding tale of PECAM-1. FEBS Lett. 2003, 540:7-14.
53. Johnson A.E., Le I.P., Buchwalter A., Burnatowska-Hledin M.A. Estrogen dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Mol. Cell. Biochem. 2007, 301:13-20.
54. Johnson A.E., Le I.P., Andresen B.T., Stodola J., Dewey G.L., Dean S.B., Resau J., Haak P., Ruch T., Sartor A., Lazdins I., Barney C.C., Burnatowska-Hledin M.A. VACM-1/cul5 expression in vascular tissue invivo is induced by water deprivation and its expression invitro regulates aquaporin-1 concentrations. Cell Tissue Res. 2012, 349:527-539.
55. Kalla C., Scheuermann M.O., Kube I., Schlotter M., Mertens D., Döhner H., Stilgenbauer S., Lichter P. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B. Eur. J. Cancer 2007, 43:1328-1335.
56. Kamitani T., Kito K., Nguyen H.P., Yeh E.T. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 1997, 272:28557-28562.
57. King L.S., Agre P. Pathophysiology of the aquaporin water channels. Annu. Rev. Physiol. 1996, 58:619-648.
58. King L.S., Nielsen S., Agre P., Brown R.H. Decreased pulmonary vascular permeability in aquaporin-1-null humans. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1059-1063.
59. Kipreos E.T., Lander L.E., Wing J.P., He W.W., Hedgecock E.M. Cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 1996, 85:829-839.
60. Kohroki J., Nishiyama T., Nakamura T., Masuho Y. ASB proteins interact with cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett. 2005, 579:6796-6802.
61. Laszlo G.S., Cooper J.A. Restriction of Src activity by cullin-5. Curr. Biol. 2009, 19:157-162.
62. Le I.P., Schultz S., Andresen B.T., Dewey G.L., Zhao P., Listenberger L., Deen P.M., Buchwalter A., Barney C.C., Burnatowska-Hledin M.A. Aquaporin-2 levels invitro and invivo are regulated by VACM-1 a cul 5 gene. Cell. Physiol. Biochem. 2012, 30:1148-1158.
63. Lee Y.J., Lee J.E., Choi H.J., Lim J.S., Jung H.J., Baek M.C., Frøkiær J., Nielsen S., Kwon T.H. E3 ubiquitin-protein ligases in rat kidney collecting duct: response to vasopressin stimulation and withdrawal. Am. J. Physiol. 2011, 301:F883-F896.
64. Leitch V., Agre P., King L.S. Altered ubiquitination and stability of aquaporin-1 in hypertonic stress. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2894-2898.
65. Li Y.F., Wang X. The role of the proteasome in heart disease. Biochem. Biophys. Acta 2011, 1809:141-149.
66. Liu X.S., Chopp M., Wang X.L., Zhang L., Hozeska-Solgot A., Tang T., Kassis H., Zhang R.L., Chen C., Xu J., Zhang Z.G. MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke. J. Biol. Chem. 2013, 288:12478-12488.
67. Liu B., Sarkis P.T., Luo K., Yu Y., Yu X.F. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J. Virol. 2005, 79:9579-9587.
68. Lubbers J., Lewis S., Harper E., Hledin M.P., Marquez G.A., Johnson A.E., Graves D.G., Burnatowska-Hledin M.A. Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells. Cell. Biol. Toxicol. 2010, 27:95-105.
69. Luo K., Ehrlich E., Xiao Z., Zhang W., Ketner G., Yu X.F. Adenovirus E4orf6 assembles with cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV, Vif-like BC-box to regulate p53. FASEB J. 2007, 21:1742-1750.
70. Ma T., Yang B., Gillespie A., Carlson E.J., Epstein C.J., Verkman A.S. Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J. Biol. Chem. 1998, 273:4296-4299.
71. Maestroni A., Ruggieri D., Dell'Antonio G., Luzi L., Zerbini G. C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway. Eur. J. Endocrinol. 2005, 152:135-141.
72. 1to-S-phase transition and identifies a conserved family of proteins. Mol. Cell. Biol. 1996, 16:6634-6643.
73. Mazal P.R., Susani M., Wrba F., Haitel A. Diagnostic significance of aquaporin-1 in liver tumors. Hum. Pathol. 2005, 36:1226-1231.
74. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
75. Mobasheri A., Airley R., Hewitt S.M., Marples D. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. Int. J. Oncol. 2005, 26:1149-1158.
76. Monzani E., Bazzottti R., Perego C., La Porta C.A. AQP1 is not only a water channel: it contributes to cell migration through Lin7/ceta-catenin. PLoS One 2009, 4:e6167.
77. Moon C., Soria J.C., Jang S.J., Lee J., Hoque M., Sibony M., Trink B., Chang Y.S., Sidransky D., Mao L. Involvement of aquaporins in colorectal carcinogenesis. Oncogene 2003, 22:6699-6703.
78. Nielsen S., Frøkiær J., Marples D., Kwon T.H., Agre P., Knepper M.A. Aquaporins in the kidney: from molecules to medicine. Physiol. Rev. 2002, 82:205-244.
79. Olive V., Bennett M.J., Walker J.C., Ma C., Jiang I., Cordon-Cardo C., Li Q.J., Lowe S.W., Hannon G.J., He L. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009, 23:2839-2849.
80. Ozu M. On the role of aquaporins in myocardial injury. Biochem. Pharmacol. 2014, 3:e155. 10.4172/2167-0501.1000e155.
81. Pan Z.Q., Kentsis A., Dias D.C., Yamoah K., Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 2004, 23:1985-1997.
82. Pagan J., Seto T., Pagano M., Cittadini A. Role of the ubiquitin proteasome system in the heart. Circ. Res. 2013, 112:1046-1058.
83. Pelham C.J., Ketsawatsomkron P., Groh S., Grobe J.L., de Lange W.J., Ibeawuchi S.R., Keen H.L., Weatherford E.T., Faraci F.M., Sigmund C.D. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase. Cell Metab. 2012, 16:462-472.
84. Petroski M.D., Deshaies R.J. Function and regulation of cullin-ring ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6:9-20.
85. Powell S.R. The ubiquitin-proteasome system in cardiac physiology and pathology. Am. J. Physiol. 2006, 291:H1-H19.
86. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a cullin-containing complex. Genes Dev. 2001, 15:3104-3117.
87. Rabut G., Peter M. Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 2008, 9:969-976.
88. Rizzoni D., Paini A., Salvetti M., Rossini C., De Ciuceis C., Rosei C.A., Muiesan M.L. Inhibitors of angiogenesis and blood pressure. Curr. Cardiovasc. Risk Rep. 2013, 7:244-247.
89. Rutkovskiy A., Valen G., Vaage J. Cardiac aquaporins. Basic Res. Cardiol. 2013, 108:393. 10.1007/s00395-013-0393-6.
90. Saadoun S., Papadopoulos M.C., Hara-Chikuma M., Verkman A.S. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005, 434:786-792.
91. Saha A., Deshaies R.J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 2008, 32:21-31.
92. Samant R.S., Clarke P.A., Workman P. E3 ubiquitin ligase Cullin 5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2014, 11:6834-6839.
93. Sartor A., Kossoris J.B., Wilcox R., Shearer R., Zeneberg A.E., Zhao P., Lazdins I., Burnatowska-Hledin M.A. Truncated form ofVACM-1/cul 5 with an extended 3' untranslated region stimulates cell growth via a MAPK-dependent pathway. Biochem. Biophys. Res. Commun. 2006, 343:1086-1093.
94. Shirwany N.A., Zou M.H. The ubiquitin proteasome system in endothelial cell dysfunction and vascular disease. Molecular and Translational Vascular Medicine 2012, vol. XIV:103-127. Humana, New York. J.W. Homeister, M.S. Willis (Eds.).
95. Soucy T.A., Smith P.G., Milhollen M.A., Berger A.J., Gavin J.M., Adhikari S., Brownell J.E., Burke K.E., Cardin D.P., Critchley S., Cullis C.A., Douchette A., Garnsey J.J., Gaulin J.L., Gershman R.E., Lublinsky A.R., McDonald A., Mizutani H., Narayanan U., Olhava E.J., Peluso S., Rezaei M., Sintchak M.D., Talreja T., Thomas M.P., Traore T., Vyskocil S., Weatherhead G.S., Yu J., Zhang J., Dick L.R., Claiborne C.F., Rolfe M., Bolen J.B., Langston S.P. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
96. Soucy T.A., Smith P.G., Rolfe M. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer. Clin. Cancer Res. 2009, 15:3192-3196.
97. Su H., Li J., Menon S., Liu J., Kumarapeli A.R., Wei N., Want X. Perturbation of cullin deneddylation by a conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice. Circ. Res. 2011, 108:40-50.
98. Sugiyama R., Nishitsuji H., Furukawa A., Katahira M., Habu Y., Takeuchi H., Ryo A., Takaku H. Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G. J. Biol. Chem. 2011, 286:10051-10057.
99. 3-pituitary vasopressin and oxytocin receptors. Prog. Brain Res. 1998, 119:147-161.
100. Thum T., Catalucci D., Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Eur. J. Cardiovasc. Res. 2008, 79:562-570.
101. Tréguer K., Heinrich E.M., Ohtani K., Bonauer A., Dimmeler S. Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J. Vasc. Res. 2011, 49:447-460.
102. Umenishi F., Schrier R.W. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. J. Biol. Chem. 2003, 278:15765-15770.
103. Vacca A., Frigeri A., Ribatti D., Nicchia G.P., Nico B., Ria R., Svelto M., Dammacco F. Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br. J. Haematol. 2001, 113:415-421.
104. Van Dort C., Zhao P., Parmele K., Capps B., Poel A., Listenberger L., Kossoris J., Wasilevich B., Murrey D., Clare P., Burnatowska-Hledin M. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am. J. Physiol. 2003, 285:C1386-C1396.
105. Ventura A., Young A.G., Winslow M.M., Lintault L., Meissner A., Erkeland S.J., Newman J., Bronson R.T., Crowley D., Stone J.R., Jaenisch R., Sharp P.A., Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132:875-886.
106. Verkman A.S. Mammalian aquaporins: diverse physiological roles and potential clinical significance. Expert Rev. Mol. Med. 2008, 10:e13.
107. Wada H., Yeh E.T., Kamitani T. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation invivo. J. Biol. Chem. 2000, 275:17008-17015.
108. Wilson A.J., Carati C.J., Gannon B.J., Haberberger R., Chataway T.K. Aquaporin-1 in blood vessels of rat circumventricular organs. Cell Tissue Res. 2010, 340:159-168.
109. Wojcik C., Di Napoli M. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Stroke 2004, 35:1506-1518.
110. Wolfe L.S., Stanley B.J., Liu C., Eliason W.K., Xiong Y. Dissection of the HIV Vif interaction with human E3 ubiquitin ligase. J. Virol. 2010, 84:7135-7139.
111. Wormald S., Hilton D.J. Inhibitors of cytokine signal transduction. J. Biol. Chem. 2004, 279:821-824.
112. Wu J.T., Lin H.C., Hu Y.C., Chien C.T. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 2005, 7:1014-1020.
113. Xu D.L., Martin P.Y., Ohara M., St John J., Pattison T., Meng X., Morris K., Kim J.K., Schrier R.W. Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J. Clin. Invest. 1997, 99:1500-1505.
114. Xu X.M., Wang X.B., Chen M.M., Liu T., Li Y.X., Jia W.H., Liu M., Tang H. MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett. 2012, 322:148-158.
115. Yang B.X., Ma T.H., Verkman A.S. Erythrocyte water permeability and renal function in double knockout mice lacking aquaporin-1 and aquaporin-3. J. Biol. Chem. 2001, 276:624-628.
116. Yin R., Bao W., Xing Y., Xi T., Gou S. MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells. Biochem. Biophys. Res. Commun. 2012, 417:771-776.
117. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
118. Yu X., Kem D.C. Proteasome inhibition during myocardial infraction. Cardiovasc. Res. 2010, 85:312-320.